Cite
APA Citation
Lu, J., Zhou, K., Yin, X., Xu, H., & Ma, B. (2019). molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer. Computational biology and chemistry, 78, 290–296. http://access.bl.uk/ark:/81055/vdc_100077456894.0x000009